Serum 24,25-dihydroxyvitamin D level in general Korean population and its relationship with other vitamin D biomarkers | PLOS ONE
![Frontiers | Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018 Frontiers | Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018](https://www.frontiersin.org/files/Articles/965376/fnut-09-965376-HTML/image_m/fnut-09-965376-g001.jpg)
Frontiers | Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018
![Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2018/06/07/19/04/vitamind_fig1_lg.jpg)
Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic
![24,25-dihydroxyvitamin D: a new biomarker in non-parathyroid hypercalcemia diagnosis - Clinical Laboratory int. 24,25-dihydroxyvitamin D: a new biomarker in non-parathyroid hypercalcemia diagnosis - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C341_Vranken_Figure-1-modifieI__e-2.jpg)
24,25-dihydroxyvitamin D: a new biomarker in non-parathyroid hypercalcemia diagnosis - Clinical Laboratory int.
![Nutrients | Free Full-Text | Prevalence and Relevance of Vitamin D Deficiency in Newly Diagnosed Breast Cancer Patients: A Pilot Study Nutrients | Free Full-Text | Prevalence and Relevance of Vitamin D Deficiency in Newly Diagnosed Breast Cancer Patients: A Pilot Study](https://www.mdpi.com/nutrients/nutrients-15-01450/article_deploy/html/images/nutrients-15-01450-g002.png)